Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Chemotherapy regimens in rare solid tumors [[electronic resource] /] / Alessandro Gommandone
| Chemotherapy regimens in rare solid tumors [[electronic resource] /] / Alessandro Gommandone |
| Autore | Comandone Alessandro |
| Pubbl/distr/stampa | Torino, : SEEd, 2011 |
| Descrizione fisica | 1 online resource (144 p.) |
| Disciplina |
617.4/4
617.44 |
| Soggetto topico |
Tumors
Chemotherapy |
| Soggetto genere / forma | Electronic books. |
| ISBN | 88-97419-08-9 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Title page; Colophon; Table of contets; Preface; 1Rare tumors of the thorax; Mesothelioma; Mesothelioma: Cisplatin + Pemetrexed; Mesothelioma: Carboplatin + Pemetrexed; Mesothelioma: Cisplatin + Gemcitabine; Mesothelioma: Cisplatin + Doxorubicin; Mesothelioma: Pemetrexed; Mesothelioma: Pemetrexed + Gemcitabine; Mesothelioma: Gemcitabine + Cisplatin; Thymoma; Thymoma: PAC; Thymoma: PACE; Thymoma: ADOC; Thymoma: PE (EORTC); 2Endocrine glands tumors; Anaplastic thyroid carcinoma; Anaplastic thyroid carcinoma: Doxorubicin + Cisplatin; Anaplastic thyroid carcinoma: Doxorubicin
Anaplastic thyroid carcinoma: Paclitaxel + GemcitabineMedullary thyroid carcinoma; Medullary thyroid carcinoma: CVD; Medullary thyroid carcinoma: Sz/M; Carcinoma of parathyroid; Parathyroid carcinoma: CFuD; Parathyroid carcinoma: Dacarbazine; Adrenocortical carcinoma; Adrenocortical carcinoma: Mitotane; Adrenocortical carcinoma: EDP/M; Adrenocortical carcinoma: EP + Mitotane; Adrenocortical carcinoma: Sz/M; Feocromocitoma; Feocromocitoma: CVD; 3Neuroendocrine tumors; Gastroenteropancreatic neuroendocrine tumors (GEP); GEP: Streptozotocin + Doxorubicin; GEP: Streptozotocin + 5-Fluorouracil GEP: FDEGEP: IFN; GEP: Octreotide LAR; GEP: Lanreotide; GEP: DTIC; Poorly-differentiated neuroendocrine tumor of different sites; Poorly-differentiated neuroendocrine tumor: PE; Poorly-differentiated neuroendocrine tumor: CAV; Poorly-differentiated neuroendocrine tumor: Topotecan; Poorly-differentiated neuroendocrine tumor: 5-Fluorouracil + Streptozotocin; Poorly-differentiated neuroendocrine tumor: EC; Poorly-differentiated neuroendocrine tumor: Etoposide orally; Poorly-differentiated neuroendocrine tumor: PEC; 4Rare gynecological tumors; Vulvar cancers Vulvar cancer: Radiotherapy + Cisplatin + 5-FluorouracilVulvar cancer: FUMIR (5-Fluorouracil + Mitomycin C + Radiotherapy); Vulvar cancer: Cisplatin + Bleomycin; Vulvar cancer: Cisplatin + 5-Fluorouracil; Vulvar cancer: Cisplatin + Vinorelbine; Uterine sarcomas; Uterine sarcomas (Leiomyosarcoma): HD-IFO; Uterine sarcomas (Leiomyosarcoma): Dacarbazine; Uterine sarcomas (Leiomyosarcoma): Dacarbazine; Uterine sarcomas (Leiomyosarcoma): Doxorubicin; Uterine sarcomas (Leiomyosarcoma): Doxorubicin + Ifosfamide; Uterine sarcomas (Leiomyosarcoma): MAID; Uterine sarcomas (Leiomyosarcoma): Trabectedin Uterine sarcomas (Leiomyosarcoma): Gemcitabine + DocetaxelCarcinosarcoma (mixed müllerian tumor): ITP; Carcinosarcoma (mixed müllerian tumor): TAP; Vaginal carcinoma; Vaginal carcinoma: Cisplatin + Vinorelbine; Vaginal carcinoma: Cisplatin + Bleomycin; Vaginal carcinoma: BIP; Vaginal carcinoma: BOMP; Vaginal carcinoma: Cisplatin + 5-Fluorouracil; Vaginal carcinoma: Cisplatin + Paclitaxel; Vaginal carcinoma: Carboplatin + Paclitaxel; 5Rare tumors of male genital tract; Testicular tumors and disgerminomas; Testicular tumors and disgerminomas: BEP; Testicular tumors: PVB Testicular tumors: VeIP (rescue regimen) |
| Record Nr. | UNINA-9910457486903321 |
Comandone Alessandro
|
||
| Torino, : SEEd, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Chemotherapy regimens in rare solid tumors [[electronic resource] /] / Alessandro Gommandone
| Chemotherapy regimens in rare solid tumors [[electronic resource] /] / Alessandro Gommandone |
| Autore | Comandone Alessandro |
| Pubbl/distr/stampa | Torino, : SEEd, 2011 |
| Descrizione fisica | 1 online resource (144 p.) |
| Disciplina |
617.4/4
617.44 |
| Soggetto topico |
Tumors
Chemotherapy |
| ISBN | 88-97419-08-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Title page; Colophon; Table of contets; Preface; 1Rare tumors of the thorax; Mesothelioma; Mesothelioma: Cisplatin + Pemetrexed; Mesothelioma: Carboplatin + Pemetrexed; Mesothelioma: Cisplatin + Gemcitabine; Mesothelioma: Cisplatin + Doxorubicin; Mesothelioma: Pemetrexed; Mesothelioma: Pemetrexed + Gemcitabine; Mesothelioma: Gemcitabine + Cisplatin; Thymoma; Thymoma: PAC; Thymoma: PACE; Thymoma: ADOC; Thymoma: PE (EORTC); 2Endocrine glands tumors; Anaplastic thyroid carcinoma; Anaplastic thyroid carcinoma: Doxorubicin + Cisplatin; Anaplastic thyroid carcinoma: Doxorubicin
Anaplastic thyroid carcinoma: Paclitaxel + GemcitabineMedullary thyroid carcinoma; Medullary thyroid carcinoma: CVD; Medullary thyroid carcinoma: Sz/M; Carcinoma of parathyroid; Parathyroid carcinoma: CFuD; Parathyroid carcinoma: Dacarbazine; Adrenocortical carcinoma; Adrenocortical carcinoma: Mitotane; Adrenocortical carcinoma: EDP/M; Adrenocortical carcinoma: EP + Mitotane; Adrenocortical carcinoma: Sz/M; Feocromocitoma; Feocromocitoma: CVD; 3Neuroendocrine tumors; Gastroenteropancreatic neuroendocrine tumors (GEP); GEP: Streptozotocin + Doxorubicin; GEP: Streptozotocin + 5-Fluorouracil GEP: FDEGEP: IFN; GEP: Octreotide LAR; GEP: Lanreotide; GEP: DTIC; Poorly-differentiated neuroendocrine tumor of different sites; Poorly-differentiated neuroendocrine tumor: PE; Poorly-differentiated neuroendocrine tumor: CAV; Poorly-differentiated neuroendocrine tumor: Topotecan; Poorly-differentiated neuroendocrine tumor: 5-Fluorouracil + Streptozotocin; Poorly-differentiated neuroendocrine tumor: EC; Poorly-differentiated neuroendocrine tumor: Etoposide orally; Poorly-differentiated neuroendocrine tumor: PEC; 4Rare gynecological tumors; Vulvar cancers Vulvar cancer: Radiotherapy + Cisplatin + 5-FluorouracilVulvar cancer: FUMIR (5-Fluorouracil + Mitomycin C + Radiotherapy); Vulvar cancer: Cisplatin + Bleomycin; Vulvar cancer: Cisplatin + 5-Fluorouracil; Vulvar cancer: Cisplatin + Vinorelbine; Uterine sarcomas; Uterine sarcomas (Leiomyosarcoma): HD-IFO; Uterine sarcomas (Leiomyosarcoma): Dacarbazine; Uterine sarcomas (Leiomyosarcoma): Dacarbazine; Uterine sarcomas (Leiomyosarcoma): Doxorubicin; Uterine sarcomas (Leiomyosarcoma): Doxorubicin + Ifosfamide; Uterine sarcomas (Leiomyosarcoma): MAID; Uterine sarcomas (Leiomyosarcoma): Trabectedin Uterine sarcomas (Leiomyosarcoma): Gemcitabine + DocetaxelCarcinosarcoma (mixed müllerian tumor): ITP; Carcinosarcoma (mixed müllerian tumor): TAP; Vaginal carcinoma; Vaginal carcinoma: Cisplatin + Vinorelbine; Vaginal carcinoma: Cisplatin + Bleomycin; Vaginal carcinoma: BIP; Vaginal carcinoma: BOMP; Vaginal carcinoma: Cisplatin + 5-Fluorouracil; Vaginal carcinoma: Cisplatin + Paclitaxel; Vaginal carcinoma: Carboplatin + Paclitaxel; 5Rare tumors of male genital tract; Testicular tumors and disgerminomas; Testicular tumors and disgerminomas: BEP; Testicular tumors: PVB Testicular tumors: VeIP (rescue regimen) |
| Record Nr. | UNINA-9910778948203321 |
|
Comandone Alessandro
|
||
| Torino, : SEEd, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Chemotherapy regimens in rare solid tumors / / Alessandro Gommandone
| Chemotherapy regimens in rare solid tumors / / Alessandro Gommandone |
| Autore | Comandone Alessandro |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Torino, : SEEd, 2011 |
| Descrizione fisica | 1 online resource (144 p.) |
| Disciplina |
617.4/4
617.44 |
| Soggetto topico |
Tumors
Chemotherapy |
| ISBN | 88-97419-08-9 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Title page; Colophon; Table of contets; Preface; 1Rare tumors of the thorax; Mesothelioma; Mesothelioma: Cisplatin + Pemetrexed; Mesothelioma: Carboplatin + Pemetrexed; Mesothelioma: Cisplatin + Gemcitabine; Mesothelioma: Cisplatin + Doxorubicin; Mesothelioma: Pemetrexed; Mesothelioma: Pemetrexed + Gemcitabine; Mesothelioma: Gemcitabine + Cisplatin; Thymoma; Thymoma: PAC; Thymoma: PACE; Thymoma: ADOC; Thymoma: PE (EORTC); 2Endocrine glands tumors; Anaplastic thyroid carcinoma; Anaplastic thyroid carcinoma: Doxorubicin + Cisplatin; Anaplastic thyroid carcinoma: Doxorubicin
Anaplastic thyroid carcinoma: Paclitaxel + GemcitabineMedullary thyroid carcinoma; Medullary thyroid carcinoma: CVD; Medullary thyroid carcinoma: Sz/M; Carcinoma of parathyroid; Parathyroid carcinoma: CFuD; Parathyroid carcinoma: Dacarbazine; Adrenocortical carcinoma; Adrenocortical carcinoma: Mitotane; Adrenocortical carcinoma: EDP/M; Adrenocortical carcinoma: EP + Mitotane; Adrenocortical carcinoma: Sz/M; Feocromocitoma; Feocromocitoma: CVD; 3Neuroendocrine tumors; Gastroenteropancreatic neuroendocrine tumors (GEP); GEP: Streptozotocin + Doxorubicin; GEP: Streptozotocin + 5-Fluorouracil GEP: FDEGEP: IFN; GEP: Octreotide LAR; GEP: Lanreotide; GEP: DTIC; Poorly-differentiated neuroendocrine tumor of different sites; Poorly-differentiated neuroendocrine tumor: PE; Poorly-differentiated neuroendocrine tumor: CAV; Poorly-differentiated neuroendocrine tumor: Topotecan; Poorly-differentiated neuroendocrine tumor: 5-Fluorouracil + Streptozotocin; Poorly-differentiated neuroendocrine tumor: EC; Poorly-differentiated neuroendocrine tumor: Etoposide orally; Poorly-differentiated neuroendocrine tumor: PEC; 4Rare gynecological tumors; Vulvar cancers Vulvar cancer: Radiotherapy + Cisplatin + 5-FluorouracilVulvar cancer: FUMIR (5-Fluorouracil + Mitomycin C + Radiotherapy); Vulvar cancer: Cisplatin + Bleomycin; Vulvar cancer: Cisplatin + 5-Fluorouracil; Vulvar cancer: Cisplatin + Vinorelbine; Uterine sarcomas; Uterine sarcomas (Leiomyosarcoma): HD-IFO; Uterine sarcomas (Leiomyosarcoma): Dacarbazine; Uterine sarcomas (Leiomyosarcoma): Dacarbazine; Uterine sarcomas (Leiomyosarcoma): Doxorubicin; Uterine sarcomas (Leiomyosarcoma): Doxorubicin + Ifosfamide; Uterine sarcomas (Leiomyosarcoma): MAID; Uterine sarcomas (Leiomyosarcoma): Trabectedin Uterine sarcomas (Leiomyosarcoma): Gemcitabine + DocetaxelCarcinosarcoma (mixed müllerian tumor): ITP; Carcinosarcoma (mixed müllerian tumor): TAP; Vaginal carcinoma; Vaginal carcinoma: Cisplatin + Vinorelbine; Vaginal carcinoma: Cisplatin + Bleomycin; Vaginal carcinoma: BIP; Vaginal carcinoma: BOMP; Vaginal carcinoma: Cisplatin + 5-Fluorouracil; Vaginal carcinoma: Cisplatin + Paclitaxel; Vaginal carcinoma: Carboplatin + Paclitaxel; 5Rare tumors of male genital tract; Testicular tumors and disgerminomas; Testicular tumors and disgerminomas: BEP; Testicular tumors: PVB Testicular tumors: VeIP (rescue regimen) |
| Record Nr. | UNINA-9910823576103321 |
|
Comandone Alessandro
|
||
| Torino, : SEEd, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||